Dr. Kapil  Kumar

Dr. Kapil Kumar

Director & HOD,Director
Fortis Hospital, Shalimar Bagh | Fortis Memorial Research Institute, Gurugram | Fortis La Femme, Greater Kailash Surgical Oncology | Onco Sciences | Gynaecology Oncology | Breast and GI-Oncology surgery | Head, Neck and Breast Oncology

View OPD Schedule

The doctor is available for consultation at multiple locations. Please choose where you would like to visit.

We use the class nav-pills instead of nav-tabs which automatically creates a background color for the tab

We applied clearfix to the tab-content to rid of the gap between the tab and the content

We use css to change the background color of the content to be equal to the tab

Doctor’s Profile

Dr. Kapil Kumar has an experience of 30 years. He is trained in Surgical Oncology at Tata Memorial Hospital, Bombay. Dr Kapil has held Senior Consultant postion at Batra Hospital, Rajiv Gandhi Cancer Institute and BLK Hospital. He is credited with setting up Robotic Surgery department at Rajiv Gandhi Cancer Institute. Dr Kapil has been a teacher of DNB Surgical Oncology since 2005. WORK EXPERIENCE: •Director- BLKCC & HOD- Surgical Oncology at BLK Super Speciality Hospital, New Delhi •Senior Consultant - Rajiv Gandhi Cancer Inst. & Research Centre, Rohini, Delhi •Consultant - Oswal Cancer Hospital, Ludhiana, Punjab •Senior Consultant - Batra Hospital and Medical Research Centre, New Delhi •Honorary Senior Consultant - Dharamshila Cancer Hospital, New Delhi SPECIALITY INTEREST: Surgical Oncology including Thoracic & GI oncology, Breast Cancer and Limb Salvage Surgery


  • •Peritoneal Echinococcus Multi Loculari's Infection: CT appearance J, Comput, Assist, Tomogr, Vol.14, No.-3, 1990. •Surgical Oncology in the third millennium: Why Sacrifice more when less will do - Journal of Safdarjang Hospital, Volume VII Jan. 2000, 31-34. •Changing concepts in Breast Cancer – Chandigarh Medical Journal - September 2002. •MRI- guided biopsy- Our preliminary experience. Indian J Radiol Imaging – August 2010. •Kras Gene Mutation and RASSF1A, FHIT & MGMT Gene Promoter Hypermethylation Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population.- April 2013 •P16(INK4a) promoter methylation and expression in sporadic breast cancer. -Journal of Carcinogenesis-Sep.2012 •MGMT & RASSF1A Gene promoter hypermethylation in sporadic colorectal cancer in Indian population. - Journal of Carcinogenesis-Sep.2012.

  • MBBS,  MS, FICS , Training in Laparoscopic Surgery- Korea, Training in HIPEC - Holland

  • •Life Member, Indian Society of Oncology (I.S.O.) •International Society of Diseases of Esophagus (I.S.D.E.) •Life Member, Delhi Medical Association (D.M.A.)

  • Dhanvantari award from Cholay1 Foundation for Onco- Surgery work


Feedback Form